Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
T2 Biosystems logo — Rapid detection of sepsis-causing pathogens

T2 Biosystems

Rapid detection of sepsis-causing pathogens

Founded 2006 United States Lexington, United States 140 employees Post Ipo Equity Total: $316.63M Biotechnology, Health Care

General Information

Company Name T2 Biosystems
Founded Year 2006
Location United States Lexington, United States +2
Employees 140
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when T2 Biosystems moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About T2 Biosystems

T2 Biosystems is dedicated to the rapid detection of sepsis-causing pathogens. The company, established in 2006 and headquartered in the United States, focuses on developing innovative diagnostic products to improve patient health, particularly targeting sepsis, hemostasis, bacteria, and Lyme disease - all areas of significant unmet medical need. Utilizing its proprietary T2 Magnetic Resonance platform (T2MR®), T2 Biosystems aims to lower mortality rates, improve patient outcomes, and reduce healthcare costs by enabling medical professionals to make targeted treatment decisions earlier. As an emerging leader in the field of in vitro diagnostics, T2 Biosystems has received a $15.00MPost-IPO Equity investment from CRG on 15 February 2024. With two FDA-cleared products targeting sepsis, the company continues to develop a broad set of applications to drive positive change in the medical diagnostic landscape. For individuals passionate about advancing healthcare, T2 Biosystems offers opportunities to contribute to its mission through open positions available at www.t2biosystems.com/careers.

Taxonomy: medical diagnostics, in vitro diagnostics, sepsis, hemostasis, bacteria, Lyme disease, pathogen detection, T2MR® technology, nanotechnology, magnetic resonance technology, rapid diagnostics, FDA-cleared products, medical innovation, health technology

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 15 May 2024
Post-IPO Equity •••••• 1
Investor
15 Feb 2024
Grant •••••• 1 •••• •••• 29 Sep 2022
Grant •••••• 1 •••• •••• 11 Sep 2019
Grant •••••• 1
Investor
08 Mar 2018

View All 14 Funding Rounds

T2 Biosystems Alternatives & Competitors

T2 Biosystems vs
Metra Biosystems
Metra Biosystems

Innovative diagnostic solutions for managing bone and joint health.

Series Unknown
Biotechnology, Health Care
Compare T2 Biosystems vs Metra Biosystems
T2 Biosystems vs
Kantum Pharma
Kantum Pharma

Developing groundbreaking therapies and innovative diagnostics to help clinicians prevent and treat...

Series A
Biopharma, Biotechnology
Compare T2 Biosystems vs Kantum Pharma
T2 Biosystems vs
Astute Medical
Astute Medical

Enhancing rapid diagnosis and risk assessment in acute medical conditions through innovative protein...

Series Unknown
Biotechnology, Health Care
Compare T2 Biosystems vs Astute Medical

FAQ About T2 Biosystems

Rapid detection of sepsis-causing pathogens
T2 Biosystems was founded in 2006.
T2 Biosystems is headquartered in Lexington, United States.
T2 Biosystems operates in the following industries: Biotechnology, Health Care.
T2 Biosystems has approximately 140 employees.
T2 Biosystems has completed 14 funding rounds, raising a total of $316.63M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to T2 Biosystems include Metra Biosystems, Kantum Pharma, Astute Medical, ARTCLINE GmbH, Diagnostic BioSystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
T2 Biosystems and Metra Biosystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors T2 Biosystems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy